What is ResearchDx?
ResearchDx operates as a specialized entity focused on the design, development, and commercialization of diagnostic solutions. The company provides a critical bridge for biopharma clients and clinical laboratories, offering services that span from initial biomarker discovery to complex regulatory consulting. With a strong operational foundation that includes ISO 13485:2016 certification, CLIA approval, and FDA registration, ResearchDx is uniquely positioned to navigate the rigorous demands of the diagnostic market. Their expertise in companion diagnostics and custom assay development allows them to streamline the path from conceptual research to market-ready clinical applications, effectively reducing the time-to-market for high-stakes medical innovations.
How much funding has ResearchDx raised?
ResearchDx has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ResearchDx
PPP
Public-Private Partnership
What's next for ResearchDx?
With this recent strategic financing, ResearchDx is poised to accelerate its expansion into advanced diagnostic modalities. The company is expected to prioritize the scaling of its laboratory operations and the enhancement of its regulatory consulting capabilities to meet the growing demand for precision medicine. By deepening its integration with biopharma partners, ResearchDx aims to further refine its assay development pipelines, ensuring that its commercialization services remain highly competitive. Future growth will likely focus on expanding its footprint in the clinical laboratory space, leveraging its existing certifications to capture a larger share of the diagnostic outsourcing market while maintaining the high-quality standards that define its current operational model.
See full ResearchDx company page
